China SXT Pharmaceuticals Inc Market Cap ($453.91K)

$453.91K USD · Rank #31110

Market Cap & Net Worth: China SXT Pharmaceuticals Inc (SXTC)

China SXT Pharmaceuticals Inc market cap. China SXT Pharmaceuticals Inc (NASDAQ:SXTC) has a market capitalization of $453.91K ($453.91K) as of November 1, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #31110 globally and #6316 in its home market, demonstrating a 6670.83% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying China SXT Pharmaceuticals Inc's stock price $3.25 by its total outstanding shares 1321418 (1.32 Million). Also see SXTC cash flow conversion for how efficiently the company converts equity into cash flow.

China SXT Pharmaceuticals Inc Market Cap History (2019–2026)

China SXT Pharmaceuticals Inc market cap history from 2019 to 2026. Data shows change from $108.36 Million to $4.29 Million (-48.38% CAGR). Check current stock price of China SXT Pharmaceuticals Inc for real-time trading data and today's change.

Index Memberships

China SXT Pharmaceuticals Inc is a constituent of 2 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NASDAQ Health Care IXHC	$2.62 Trillion	0.00%	#913 of 976
NASDAQ Composite IXIC	$40.09 Trillion	0.00%	#2883 of 3165

Weight: China SXT Pharmaceuticals Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

China SXT Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how China SXT Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore China SXT Pharmaceuticals Inc annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

4.00x

China SXT Pharmaceuticals Inc's market cap is 4.00 times its annual revenue

Industry average: 0.56x Higher than industry average

Latest Price to Earnings (P/E) Ratio

N/A

P/E ratio not applicable due to negative or zero earnings

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2019	$108.36 Million	$7.01 Million	$1.54 Million	15.45x	70.40x
2020	$43.47 Million	$5.16 Million	-$10.29 Million	8.42x	N/A
2021	$21.47 Million	$4.78 Million	-$2.75 Million	4.49x	N/A
2022	$17.91 Million	$2.60 Million	-$5.74 Million	6.88x	N/A
2023	$5.25 Million	$1.97 Million	-$5.93 Million	2.66x	N/A
2024	$671.41K	$1.93 Million	-$3.10 Million	0.35x	N/A
2025	$2.11 Million	$1.74 Million	-$3.30 Million	1.21x	N/A
2026	$4.29 Million	$1.07 Million	-$6.21 Million	4.00x	N/A

Competitor Companies of SXTC by Market Capitalization

Companies near China SXT Pharmaceuticals Inc in the global market cap rankings as of November 1, 2026. Also see balance sheet size of China SXT Pharmaceuticals Inc for a full breakdown of the balance sheet.

Key companies related to China SXT Pharmaceuticals Inc by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #511 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #535 globally with a market cap of $50.42 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #593 globally with a market cap of $45.23 Billion USD ( CN¥309.13 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #619 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#511	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#535	GALDERMA GROUP AG	NYSE:GALDY	$50.42 Billion	$46.62
#593	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$45.23 Billion	CN¥48.46
#619	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€18.30

Market Capitalization of China SXT Pharmaceuticals Inc (2019–2026)

Market capitalization of China SXT Pharmaceuticals Inc from 2019 to today. Between 2019 and today, China SXT Pharmaceuticals Inc's market cap moved from $108.36 Million to $ 4.29 Million, with a yearly change of -48.38%.

Year	Market Cap	Change (%)
2026	$4.29 Million	+103.12%
2025	$2.11 Million	+214.90%
2024	$671.41K	-87.20%
2023	$5.25 Million	-70.70%
2022	$17.91 Million	-16.62%
2021	$21.47 Million	-50.61%
2020	$43.47 Million	-59.88%
2019	$108.36 Million	--

End of Day Market Cap According to Different Sources

On Oct 31st, 2026 the market cap of China SXT Pharmaceuticals Inc was reported to be:

Source	Market Cap
Yahoo Finance	$453.91K USD
MoneyControl	$453.91K USD
MarketWatch	$453.91K USD
marketcap.company	$453.91K USD
Reuters	$453.91K USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About China SXT Pharmaceuticals Inc

NASDAQ:SXTC USA Drug Manufacturers - Specialty & Generic

Market Cap

$4.29 Million

Market Cap Rank

#31110 Global

#6316 in USA

Share Price

$3.25

Change (1 day)

-8.45%

52-Week Range

$0.03 - $5.13

All Time High

$1195.00